Toleranzia AB
Toleranzia AB (publ), a biotechnology company, develops and commercializes drugs for the treatment of autoimmune orphan diseases. The company is primarily developing TOL2 drug candidate in clinical trial for treating myasthenia gravis, an autoimmune nerve and muscle disease. The company also develops TOL3 drug candidate for the treatment of ANCA vasculitis, an autoimmune blood vessel disease. In … Read more
Toleranzia AB (TOL) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.023x
Based on the latest financial reports, Toleranzia AB (TOL) has a cash flow conversion efficiency ratio of -0.023x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-3.98 Million) by net assets (Skr173.87 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Toleranzia AB - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Toleranzia AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Toleranzia AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Toleranzia AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Chih Lien Industrial Co Ltd
TW:2024
|
0.013x |
|
SAGTEC GLOBAL LIMITED Ordinary shares
NASDAQ:SAGT
|
0.449x |
|
Introl S.A.
WAR:INL
|
0.131x |
|
Container Store Group Inc
NYSE:TCS
|
0.096x |
|
Dycasa SA
BA:DYCA
|
-0.135x |
|
Maritime Resources Corp
PINK:MRTMF
|
0.038x |
|
2P30
F:2P30
|
-0.242x |
|
Trigyn Technologies Limited
NSE:TRIGYN
|
-0.080x |
Annual Cash Flow Conversion Efficiency for Toleranzia AB (2014–2024)
The table below shows the annual cash flow conversion efficiency of Toleranzia AB from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr180.07 Million | Skr-10.28 Million | -0.057x | -38.60% |
| 2023-12-31 | Skr153.52 Million | Skr-6.32 Million | -0.041x | +31.64% |
| 2022-12-31 | Skr119.51 Million | Skr-7.20 Million | -0.060x | -12.56% |
| 2021-12-31 | Skr127.97 Million | Skr-6.85 Million | -0.054x | +8.91% |
| 2020-12-31 | Skr67.92 Million | Skr-3.99 Million | -0.059x | +53.62% |
| 2019-12-31 | Skr34.99 Million | Skr-4.43 Million | -0.127x | +27.53% |
| 2018-12-31 | Skr27.59 Million | Skr-4.82 Million | -0.175x | +54.26% |
| 2017-12-31 | Skr14.67 Million | Skr-5.61 Million | -0.382x | -46.00% |
| 2016-12-31 | Skr20.06 Million | Skr-5.25 Million | -0.262x | -90.44% |
| 2015-12-31 | Skr24.45 Million | Skr-3.36 Million | -0.137x | +74.75% |
| 2014-12-31 | Skr1.72 Million | Skr-935.22K | -0.544x | -- |